Yoshido, A., Ishiguro, K., Kitajima, H., Niinuma, T., Kumegawa, K., Maezawa, M., Tsukahara, T., Toyota, M., Yorozu, A., Sasaki, H., Yamamoto, E., Kai, M., Idogawa, M., Torigoe, T., Nakase, H., Maruyama, R. and Suzuki, H.

DOT1L inhibition exerts the anti-tumor effect by activating interferon signaling in breast cancer cells.
Clin. Epigenetics, 17, 201 (2025)

Hori, C., Kumegawa, K., Saeki, S., Takahashi, Y., Yang, L., Nakadai, T., Otsuji, K., Takahata, C., Ozaki, Y., Uehiro, N., Haruyama, Y., Osako, T., Takano, T., Mori, S., Noda, T., Fujii, S., Ohno, S., Ueno, T. and Maruyama, R.

Characterizing heterogeneous cis-regulatory elements in gene regulatory programs associated with breast cancer.
Genome Med, 17, 145 (2025)

Kakuto, S., Uchibori, K., Yamamoto, Y., Miyauchi, E., Nishio, M., Sugiura, H. and Katayama, R.

Tumor heterogeneity involving SCLC with a single exon deletion in RB1 and adenocarcinoma with EGFR-L718V mutation in EGFR-TKI resistant lung cancer.
Lung Cancer, 108833 (2025)

Haga, Y.

Clinical glycoproteomics in cancer: toward tissue-based glycoform profiling and biomarker discovery.
J. Biochem.,  mvaf063 (2025)

Qian, J., Watanabe, T., Watanabe, R., Kanno, S., Takahashi, A., Kohsaka, S., Yoshino, Y., Chiba, N., Kohno, T., Tanaka, K., Yasui, A. and Ui, A.

BET family, BRD3 initiates DSB-induced chromatin remodeling with TIP60 to promote R-loop–mediated HR.
Cell Rep.,  in press (2025)

more